EKIPS Technologies, Inc.
EKIPS Technologies utilizes mid-IR laser technology to rapidly measusre subparts per billion concentrations of nitric oxide (NO).
Oklahoma Medical Research Foundation has developed a highly effective and safe therapeutic for the treatment of glioblastoma. The compound, OKN-007, has the unique ability to cross the blood-brain barrier and has been successfully shown to decrease both tumor size and tumor vasculature in animal models of glioblastoma.
Cytovance Biologics is a biopharmaceutical contract manufacturer of therapeutic proteins and antibodies from mammalian cell culture and microbial fermentation.
Otologic Pharmaceutics, Inc. (OP) is an Oklahoma-headquartered organization formed specifically to commercialize promising technologies that address novel pharmacological solutions for hearing and balanced health.
UltraBotanica developed a method to bind curcumin to whey protein – effectively increasing the bioavailability by more than 15,000 times.
PolySkope Labs provides the best service and offers the?most advanced technology in the food safety industry.
Moleculera Labs provides personalized clinical testing services for individuals suspected of suffering from PANDAS/PANS, which are treatable neurologic conditions that may be associated with motor tics, obsessive compulsive disorders (OCD) and sometimes Autism Spectrum Disorders.
IMMY delivers diagnostics that can be performed without high-technology laboratory equipment or even electricity in general.
Hyalose, LLC is a biotechnology company focused on the commercialization of unique recombinant technologies for producing Hyaluronic Acid (HA), an important biomolecule for many healthcare and cosmetic applications.
Progentec uses a lab-based assay to detect lupus flares as early as 6-12 weeks before flares happen.
Charlesson, an Oklahoma-based pharmaceutical company, is actively engaged in the development of therapeutics for treating debilitating ophthalmic diseases. Their product pipeline includes pharmaceutical treatments for Age-Related Macular Degeneration, Diabetic Retinopathy, Ocular Inflammation, Angiogenesis, and systemic diabetes.
Jortan is developing a novel approach to the treatment of Type-2 diabetes.
Biolytx’s core technology is the development of a novel antibiotic peptide for use in treatment of serious hospital-acquired infections, including those resistant to current antibiotics.
Drik is a pre clinical toxicology services laboratory for drug safety evaluation. They do preclinical screening tests for cosmetic industry and non clinical toxicology testing for chemical manufacturing.
COARE Biotechnology is a research driven pharmaceutical company dedicated to developing novel therapeutic agents designed to treat solid tumor cancers.
Pamlico BioPharma develops fully-human antibody therapeutics for infectious diseases.
Arthrokinex is a comprehensive joint health program that can reduce or eliminate joint pain from osteoarthritis through the healing powers of the patient’s own blood without complications.
Crescendo Bioscience is a molecular diagnostics laboratory focused on rheumatology.
EpimedX, LLC is an Oklahoma-based biotechnology company with the mission to develop Gene Regulation Therapy ? a promising technology that is expected to provide a safe, cost-effective and permanent treatment for sickle cell disease, beta-thalassemia and malaria without dangerous or harmful side effects.
Mintiva develops products specially formulated for distinct topical applications.
Selexys Pharmaceuticals? pioneering work on the molecular mechanisms of inflammation has led to breakthroughs in novel therapeutics for inflammatory and thrombotic diseases and positioned Selexys with strong scientific underpinnings.
